Literature DB >> 1687444

The cellular basis of delirium and its relevance to age-related disorders including Alzheimer's disease.

G E Gibson1, J P Blass, H M Huang, G B Freeman.   

Abstract

A wide variety of conditions lead to delirium (i.e., metabolic encephalopathies) in human beings and animals. Despite the varied etiology the clinical consequences are relatively stereotyped which suggests that the diverse insults that cause delirium may act by common metabolic and cellular "final pathways." Related molecular and cellular mechanisms may be involved in aging and Alzheimer's disease, conditions that predispose to the development of delirium. Animal models of delirium better reflect age-related disorders such as Alzheimer's disease than those that impair a single neurotransmitter system such as the cholinergic system; the metabolic encephalopathies produce global cognitive disturbance, which is more typical of these disorders. Thus, research related to delirium has far-reaching implications for normal and abnormal brain function.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1687444     DOI: 10.1017/s1041610291000820

Source DB:  PubMed          Journal:  Int Psychogeriatr        ISSN: 1041-6102            Impact factor:   3.878


  11 in total

Review 1.  Drug-induced cognitive impairment in the elderly.

Authors:  A R Moore; S T O'Keeffe
Journal:  Drugs Aging       Date:  1999-07       Impact factor: 3.923

2.  Proton Magnetic Resonance Spectroscopy in adult cancer patients with delirium.

Authors:  Jeffrey R Yager; Vincent A Magnotta; James A Mills; Stacie M Vik; Michelle T Weckmann; Aristides A Capizzano; Roger Gingrich; Leigh J Beglinger
Journal:  Psychiatry Res       Date:  2011-01-11       Impact factor: 3.222

Review 3.  Psychotic manifestations of alcoholism.

Authors:  D M Greenberg; J W Lee
Journal:  Curr Psychiatry Rep       Date:  2001-08       Impact factor: 5.285

4.  Abnormalities in the tricarboxylic acid (TCA) cycle in the brains of schizophrenia patients.

Authors:  P Bubber; V Hartounian; G E Gibson; J P Blass
Journal:  Eur Neuropsychopharmacol       Date:  2010-11-30       Impact factor: 4.600

5.  A long-term follow-up study of cerebrospinal fluid acetylcholinesterase in delirium.

Authors:  H J Koponen; J Sirviö; U Lepola; E Leinonen; P J Riekkinen
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1994       Impact factor: 5.270

6.  Mitochondrial enzymes in schizophrenia.

Authors:  Parvesh Bubber; Jicheng Tang; Vahram Haroutunian; Hui Xu; Kenneth L Davis; John P Blass; Gary E Gibson
Journal:  J Mol Neurosci       Date:  2004       Impact factor: 3.444

Review 7.  The association between delirium and cognitive decline: a review of the empirical literature.

Authors:  James C Jackson; Sharon M Gordon; Robert P Hart; Ramona O Hopkins; E Wesley Ely
Journal:  Neuropsychol Rev       Date:  2004-06       Impact factor: 7.444

Review 8.  Drugs with anticholinergic properties: cognitive and neuropsychiatric side-effects in elderly patients.

Authors:  Iacopo Cancelli; Massimiliano Beltrame; Gian Luigi Gigli; Mariarosaria Valente
Journal:  Neurol Sci       Date:  2009-02-20       Impact factor: 3.307

9.  A long-term follow-up study of cerebrospinal fluid 5-hydroxyindoleacetic acid in delirium.

Authors:  H J Koponen; U Lepola; E Leinonen
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1994       Impact factor: 5.270

10.  A clinical update on delirium: from early recognition to effective management.

Authors:  Joaquim Cerejeira; Elizabeta B Mukaetova-Ladinska
Journal:  Nurs Res Pract       Date:  2011-06-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.